Quick recap

The webinar featured Dr. Regina, a functional medicine certified physician, who presented on Holistic Heart Centers and their precision cardiology approach focused on heart health optimization and longevity. She discussed the integration of diagnostics, labs, and wearables through the Heads Up platform and introduced digital biomarkers as key data points for assessing patient health trajectories. The presentation covered the importance of prevention in cardiovascular health, the role of integrative cardiology, and the use of medical-grade genetic data in assessing cardiovascular risk, and concluding with a demonstration of digital biomarkers in clinical practice.

Summary

Heads Up Platform Integration Webinar

David welcomed Dr. Regina to the webinar, highlighting her expertise in integrative cardiology and her contributions to previous webinars. Dr. Regina discussed the integration of diagnostics, labs, and wearables through the Heads Up platform, which synthesizes fragmented data to provide actionable insights for practitioners and patients. The webinar will conclude with a summary Q&A session and the announcement of giveaway winners.

Precision Cardiology and Digital Biomarkers

Dr. Regina, a functional medicine certified physician, presented on Holistic Heart Centers, a precision cardiology practice focused on heart health optimization and longevity. She discussed the importance of prevention in cardiovascular health and introduced digital biomarkers, which are data points collected from wearables and other devices that can provide insights into a patient’s health trajectory. Dr. Regina explained the difference between disease management and health optimization in cardiology, emphasizing the need for a new toolkit to guide patient health in the latter. She also highlighted the role of integrative cardiology and shared real patient cases to demonstrate the potential of digital biomarkers in improving patient care.

Integrative Cardiology: Precision and Personalization

The discussion focused on integrative cardiology, a framework that combines precision medicine with personalized lifestyle and therapeutic interventions to address residual cardiovascular risk beyond conventional treatments. The MI3 (Metabolic, Inflammatory, Immune, and Infectious) framework was introduced as a comprehensive approach to assess patients’ health across multiple domains, including hereditary predispositions, hormonal balance, and stress patterns. The speaker emphasized the importance of structured programs and digital biomarkers in documenting patient progress, while highlighting the need for a science-enhanced, data-driven approach to integrative cardiology.

Genetic Data for Cardiovascular Risk

Regina explained the use of medical-grade genetic data, including monogenic and polygenic scores, to assess cardiovascular risk. She highlighted that while large-effect genetic variants for conditions like familial hypercholesterolemia are rare, smaller genetic variants are more common and can contribute significantly to risk. Regina emphasized the importance of transitioning from known cardiovascular risk factors to identifying new patterns and strategies through data-driven approaches, including digital biomarkers and AI-powered decision support. She also discussed the challenges of insurance reimbursement for these advanced diagnostic tools and suggested alternative, more affordable options through direct purchasing.

Genetic and Biomarker Insights for LP(a)

Dr. Regina discussed the genetic component of LP(a), noting that 90% is genetic. She addressed HRT in women with a positive family history of CBD, emphasizing risk management and the importance of addressing cardiometabolic factors. Dr. Regina also explained the role of Ripatha, a PCSK9 inhibitor, in reducing LDL cholesterol and its potential impact on LP(a). She highlighted two digital biomarkers, metabolic age and vascular age, which can help assess biological aging and cardiovascular risk beyond chronological age. These measurements can be influenced by interventions such as physical activity and nutrition.

Digital Biomarkers in Clinical Practice

Regina presented on integrating digital biomarkers into clinical practice, focusing on metabolic and vascular age assessments using wearable devices like Withings scales. She demonstrated how to analyze patient data to track improvements and identify areas needing attention, such as sleep quality and lifestyle factors. The discussion covered the limitations and potential of digital biomarkers, emphasizing the importance of synthesizing traditional and digital data for comprehensive patient care. David and Angela announced giveaway winners and encouraged participants to book demos to learn more about implementing these tools in their practices.